Frontlight ResearchEarly access
Taking peopleNo phase
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Key facts
- Who runs it
- Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
- Where
- Netherlands3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 3,300 people, planned
- Started
- 25 Oct 2022
- Planned end
- 1 Oct 2026
- Type of study
- Observational
- Record updated
- 2 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age 18 years or higher
- Presentation at the Emergency Department (ED)
- Clinical suspicion of infection or earlier confirmed infection
- Modified Early Warning Score (MEWS) of 2 or higher
Who cannot take part
- No informed consent given
This trial is currently available in Netherlands.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Objectives:
Read full original descriptionShow less
1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection. 2. To determine immune response aberrations that are associated with an increased risk of developing sepsis in patients presenting to the ED with a(n) (suspected) infection without sepsis. 3. To determine the long term cognitive and physical sequelae of sepsis after admission.
The group in the trial
- Patients with infection
Patients with an (suspected) infection and a MEWS score 2 or higher
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 2 October 2025